Literature DB >> 28160945

In search of new α-glucosidase inhibitors: Imidazolylpyrazole derivatives.

Faryal Chaudhry1, Sadia Naureen2, Rahila Huma3, Ayesha Shaukat4, Mariya Al-Rashida5, Nadia Asif2, Mohammad Ashraf6, Munawar Ali Munawar7, Misbahul Ain Khan8.   

Abstract

Under three different reaction conditions (conventional heating, microwave irradiations and amino acid catalysis), a series of imidazolylpyrazoles (2a-2k) were synthesized in good to excellent yields from a mixture of three precursors: aryl(hetaryl)pyrazole-4-carbaldehydes (1a-1k), benzil and ammonium acetate. α-Glucosidase inhibition assay revealed a new class of highly potent agents wherein each compound displayed significant inhibitory potentials (in terms of percentage inhibition and relative IC50 values) as compared to that of the reference drug (Acarbose). Moreover, molecular modelling of most potent compounds 2h, 2j and 2k also helped in understanding the structure and activity relationship.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Docking; Imidazolylpyrazoles; Multicomponent reaction; α-Glucosidase inhibition

Mesh:

Substances:

Year:  2017        PMID: 28160945     DOI: 10.1016/j.bioorg.2017.01.017

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  11 in total

1.  Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies.

Authors:  Fariba Peytam; Mehdi Adib; Reihaneh Shourgeshty; Maryam Mohammadi-Khanaposhtani; Mehdi Jahani; Somaye Imanparast; Mohammad Ali Faramarzi; Mohammad Mahdavi; Ali Akbar Moghadamnia; Hossein Rastegar; Bagher Larijani
Journal:  Mol Divers       Date:  2019-03-02       Impact factor: 2.943

2.  Synthesis, in vitro [Formula: see text]-glucosidase inhibitory activity, and in silico study of (E)-thiosemicarbazones and (E)-2-(2-(arylmethylene)hydrazinyl)-4-arylthiazole derivatives.

Authors:  Muhammad Ali; Khalid Mohammed Khan; Uzma Salar; Mohammed Ashraf; Muhammad Taha; Abdul Wadood; Sujhla Hamid; Muhammad Riaz; Basharat Ali; Shahbaz Shamim; Farman Ali; Shahnaz Perveen
Journal:  Mol Divers       Date:  2018-05-29       Impact factor: 2.943

Review 3.  Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review.

Authors:  Khalid Karrouchi; Smaail Radi; Youssef Ramli; Jamal Taoufik; Yahia N Mabkhot; Faiz A Al-Aizari; M'hammed Ansar
Journal:  Molecules       Date:  2018-01-12       Impact factor: 4.411

Review 4.  Recent Applications of the Multicomponent Synthesis for Bioactive Pyrazole Derivatives.

Authors:  Diana Becerra; Rodrigo Abonia; Juan-Carlos Castillo
Journal:  Molecules       Date:  2022-07-23       Impact factor: 4.927

5.  Sustainable Synthetic Approach for (Pyrazol-4-ylidene)pyridines By Metal Catalyst-Free Aerobic C(sp2)-C(sp3) Coupling Reactions between 1-Amino-2-imino-pyridines and 1-Aryl-5-pyrazolones.

Authors:  Hamada Mohamed Ibrahim; Haider Behbehani
Journal:  ACS Omega       Date:  2019-07-05

Review 6.  Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review.

Authors:  Wan-Yin Fang; L Ravindar; K P Rakesh; H M Manukumar; C S Shantharam; Njud S Alharbi; Hua-Li Qin
Journal:  Eur J Med Chem       Date:  2019-04-10       Impact factor: 6.514

7.  Synthesis, Type II diabetes inhibitory activity, antimicrobial evaluation and docking studies of indeno[1,2-c]pyrazol-4(1H)-ones.

Authors:  Satbir Mor; Suchita Sindhu
Journal:  Med Chem Res       Date:  2019-10-26       Impact factor: 1.965

8.  One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors.

Authors:  Malihe Karami; Alireza Hasaninejad; Hossein Mahdavi; Aida Iraji; Somayeh Mojtabavi; Mohammad Ali Faramarzi; Mohammad Mahdavi
Journal:  Mol Divers       Date:  2021-10-25       Impact factor: 3.364

9.  Design, synthesis, biological evaluation, and molecular modeling studies of pyrazole-benzofuran hybrids as new α-glucosidase inhibitor.

Authors:  Fateme Azimi; Homa Azizian; Mohammad Najafi; Ghadamali Khodarahmi; Lotfollah Saghaei; Motahareh Hassanzadeh; Jahan B Ghasemi; Mohammad Ali Faramarzi; Bagher Larijani; Farshid Hassanzadeh; Mohammad Mahdavi
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

10.  Arylsulfonyl histamine derivatives as powerful and selective α-glucosidase inhibitors.

Authors:  M I Osella; M O Salazar; M D Gamarra; D M Moreno; F Lambertucci; D E Frances; R L E Furlan
Journal:  RSC Med Chem       Date:  2020-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.